Marcela Maus

Marcela Maus, M.D., Ph.D., is the Director of Cellular Immunotherapy at the Massachusetts General Hospital (MGH) Cancer Center. She is a member of the Center for Cancer Immunology and the Department of Medicine at the MGH, and an Assistant Professor at Harvard Medical School. Her laboratory is generating new forms of chimeric antigen receptors directed to new targets and bringing them to the clinical setting to treat patients with hematologic malignancies and solid tumors.

Dr. Maus trained in internal medicine at the University of Pennsylvania and at Memorial Sloan Kettering Cancer Center as a hematologist and medical oncologist. Dr. Maus’ post-doctoral work was with Michel Sadelain and Carl June, where she focused on pre-clinical development and correlative studies relevant to T-cell immunotherapies, designing early-phase trials of T-cell therapies for multiple myeloma, chronic lymphocytic leukemia, and glioblastoma.